Sprint Bioscience AB Sustainability Reports
Sprint Bioscience AB is a pharmaceutical company that focuses on the preclinical research and development of small-molecule drug candidates, particularly within the oncology sector. The company utilizes a proprietary fragment-based drug discovery platform to efficiently design programs and out-license them to global pharmaceutical companies.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 5493006ED74WIIQOKC56
FIGI: BBG001V0FWY8
6 reports from 2020 to 2025